Cite
HARVARD Citation
Bakker, C. et al. (2021). First‐in‐man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1‐receptor partial agonist for the treatment of dementias. British journal of clinical pharmacology. 87 (7), pp. 2945-2955. [Online].